

Checkpoint Inhibitors: What Generalists Need to Know
Apr 15, 2024
Drs. Reaford Blackburn Jr. and Brian C. Westbrook discuss immune-related adverse events from checkpoint inhibitors, highlighting the mechanisms of action, management of adverse events, patient response variations, and the importance of early recognition by healthcare providers.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Checkpoint Inhibitors in Cancer Treatment
02:37 • 9min
Understanding Immune-Related Adverse Events Caused by Checkpoint Inhibitors
11:38 • 3min
Clinical Decision-making and Evaluation of Checkpoint Inhibitor Adverse Reactions
14:51 • 3min
Recognizing Checkpoint Inhibitor Toxicities in Patients
17:38 • 5min